You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 147 No. 2, February 1993 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ARTICLES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (20)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Hypertrophic Cardiomyopathy During Corticotropin Therapy for Infantile Spasms

A Clinical and Echocardiographic Study

Gary B. Bobele, MD; Kent E. Ward, MD; John B. Bodensteiner, MD

Am J Dis Child. 1993;147(2):223-225.


Abstract



• Objective.
—To evaluate the incidence and clinical features of abnormal cardiac hypertrophy during treatment of infantile spasms with corticotropin.

Design.
—A prospective, echocardiographic study. Participants.—Eighteen children treated for infantile spasms with high-dose corticotropin at a large tertiary children's hospital.

Interventions.
—None.

Measurements and Results.
—Abnormal cardiac hypertrophy was seen in 13 (72%) of 18 patients. Five of 18 patients (group 1) developed hypertrophic cardiomyopathy with asymmetric septal hypertrophy; none developed significant left ventricular outflow obstruction. Concentric left ventricular hypertrophy was seen in eight patients (group 2), whereas no changes were observed in five (group 3).

Conclusion.
—Abnormal venricular hypertrophy occurs in the majority of patients treated with corticotropin for infantile spasms. In our study, many of these patients developed hypertrophic cardiomyopathy with dramatic asymmetric septal hypertrophy; however, none developed significant obstruction to left ventricular outflow. All changes were reversible, and did not require premature discontinuation of therapy.

(AJDC. 1993;147:223-225)



Author Affiliations



From the Departments of Neurology (Dr Bobele) and Pediatrics (Dr Ward), University of Oklahoma Health Science Center, Oklahoma City, and the Department of Neurology, West Virginia University School of Medicine, Morgantown (Dr Bodensteiner).


Footnotes



Accepted for publication September 23, 1992.

Presented in part at the Child Neurology Society Annual Meeting, Portland, Ore, October 4, 1991.

Reprint requests to Department of Neurology, University of Oklahoma Health Science Center, PO Box 26307, Oklahoma City, OK 73126 (Dr Bobele).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Low-dose ACTH therapy for West syndrome: Initial effects and long-term outcome
Ito et al.
Neurology 2002;58:110-114.
ABSTRACT | FULL TEXT  

Medical Treatment of West Syndrome in Japan
Watanabe
J Child Neurol 1995;10:143-147.
ABSTRACT  

The Treatment of Infantile Spasms by Child Neurologists
Bobele and Bodensteiner
J Child Neurol 1994;9:432-435.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.